In a modeled analysis of the economic impact of vaccine use in the world’s 72 poorest countries, for countries included in the analyses from the African region, scaling up coverage of the Rotavirus (RVV) vaccine to 90% was projected to result in more than US$900 million in treatment costs averted.
Full Citation:
Stack, M. L., Ozawa, S., Bishai, D. M., et al.. 2011. Estimated Economic Benefits During The ‘Decade Of Vaccines’ Include Treatment Savings, Gains In Labor Productivity. Health Affairs. 30(6).
Title of Article: Estimated Economic Benefits During The ‘Decade Of Vaccines’ Include Treatment Savings, Gains In Labor Productivity
Author(s): Stack, M. L., Ozawa, S., Bishai, D. M., et al.
Publication Year: 2011
Publication Name: Health Affairs
Publication Volume: 30(6)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/21653952/
DOI (Digital Object Identifier): 10.1377/hlthaff.2011.0382